The cost of asthma medicines.
作者信息
Reddel Helen K, Lembke Kirsty, Zwar Nicholas J
机构信息
Woolcock Institute of Medical Research, University of Sydney.
NPS MedicineWise, Sydney.
出版信息
Aust Prescr. 2018 Apr;41(2):34-36. doi: 10.18773/austprescr.2018.011. Epub 2018 Apr 3.
Abstract
摘要
相似文献
1
The cost of asthma medicines.哮喘药物的成本。
Aust Prescr. 2018 Apr;41(2):34-36. doi: 10.18773/austprescr.2018.011. Epub 2018 Apr 3.
2
Differences in medication adherence are associated with beliefs about medicines in asthma and COPD.药物依从性的差异与哮喘和慢性阻塞性肺疾病患者对药物的认知有关。
Clin Transl Allergy. 2017 Nov 10;7:39. doi: 10.1186/s13601-017-0175-6. eCollection 2017.
3
Specific, but not general beliefs about medicines are associated with medication adherence in patients with COPD, but not asthma: Cohort study in a population of people with chronic pulmonary disease.特定而非一般的药物信念与 COPD 患者的药物依从性相关，但与哮喘无关：慢性肺部疾病人群的队列研究。
J Psychosom Res. 2018 Apr;107:46-52. doi: 10.1016/j.jpsychores.2018.02.004. Epub 2018 Feb 8.
4
Clustering medication adherence behavior based on beliefs in medicines and illness perceptions in patients taking asthma maintenance medications.基于使用哮喘维持药物患者的药物信念和疾病认知对药物依从性行为进行聚类分析。
Curr Med Res Opin. 2016;32(1):113-21. doi: 10.1185/03007995.2015.1105204. Epub 2015 Nov 16.
5
"You've got to breathe, you know" - asthma patients and carers' perceptions around purchase and use of asthma preventer medicines.“你必须得呼吸，你知道的”——哮喘患者和照护者对购买和使用哮喘预防药物的看法。
Aust N Z J Public Health. 2019 Jun;43(3):207-213. doi: 10.1111/1753-6405.12865. Epub 2019 Feb 6.
6
General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study.全科医生对成本对哮喘预防药物处方影响的看法：一项定性研究。
Aust Health Rev. 2019 Jul;43(3):246-253. doi: 10.1071/AH17030.
7
Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.使用“依从性始于知识20”（ASK - 20）问卷评估日本慢性阻塞性肺疾病患者和哮喘患者吸入药物依从性障碍的差异。
Intern Med. 2019 Jan 15;58(2):175-185. doi: 10.2169/internalmedicine.0488-17. Epub 2018 Sep 12.
8
Adherence barriers to inhaled medicines in Japanese older patients with asthma evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) questionnaire.使用“依从性始于知识20”（ASK - 20）问卷评估日本老年哮喘患者吸入药物的依从性障碍。
J Asthma. 2019 Jun;56(6):632-641. doi: 10.1080/02770903.2018.1484132. Epub 2018 Sep 19.
9
A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.一项群组随机对照试验，旨在评估意大利药物使用评估（I-MUR）对哮喘患者的有效性和成本效益。
BMC Health Serv Res. 2017 Apr 24;17(1):300. doi: 10.1186/s12913-017-2245-9.
10
Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.患者对处方药的看法及其在慢性躯体疾病治疗依从性中的作用。
J Psychosom Res. 1999 Dec;47(6):555-67. doi: 10.1016/s0022-3999(99)00057-4.
引用本文的文献
1
Knowledge Mapping of COVID-19 and Asthma/Allergic Rhinitis: A Visual and Bibliometric Analysis.新型冠状病毒肺炎与哮喘/过敏性鼻炎的知识图谱：可视化与文献计量分析
J Asthma Allergy. 2025 May 6;18:705-721. doi: 10.2147/JAA.S512175. eCollection 2025.
2
GINA Implementation Improves Asthma Symptoms Control and Lung Function: A Five-Year Real-World Follow-Up Study.《全球哮喘防治创议》的实施改善了哮喘症状控制和肺功能：一项为期五年的真实世界随访研究。
J Pers Med. 2023 May 10;13(5):809. doi: 10.3390/jpm13050809.
3
A Targeted Approach to Improve Asthma Control Using Community Pharmacists.一种利用社区药剂师改善哮喘控制的针对性方法。
Front Pharmacol. 2021 Dec 27;12:798263. doi: 10.3389/fphar.2021.798263. eCollection 2021.
4
Updated Australian guidelines for mild asthma: what's changed and why?澳大利亚轻度哮喘更新指南：有哪些变化以及为何有这些变化？
Aust Prescr. 2020 Dec;43(6):220-224. doi: 10.18773/austprescr.2020.076. Epub 2020 Dec 1.
5
Medication Adherence in a Community Population with Uncontrolled Asthma.社区中未控制哮喘人群的药物依从性
Pharmacy (Basel). 2020 Oct 7;8(4):183. doi: 10.3390/pharmacy8040183.
6
Managing the overlap of asthma and chronic obstructive pulmonary disease.哮喘与慢性阻塞性肺疾病重叠的管理
Aust Prescr. 2020 Feb;43(1):7-11. doi: 10.18773/austprescr.2020.002. Epub 2020 Feb 3.
本文引用的文献
1
Encouraging adherence to long-term medication.鼓励长期药物治疗的依从性。
Aust Prescr. 2017 Aug;40(4):147-150. doi: 10.18773/austprescr.2017.050. Epub 2017 Aug 1.
2
Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia.ICS/LABA 联合用药在人群中的使用率与哮喘结局的改善是否相关？新西兰和澳大利亚全国代表性人群的横断面调查。
Respirology. 2017 Nov;22(8):1570-1578. doi: 10.1111/resp.13123. Epub 2017 Aug 9.
3
Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study.轻度哮喘患者起始吸入性皮质类固醇治疗的建议是否应基于症状频率：START 研究的事后疗效分析。
Lancet. 2017 Jan 14;389(10065):157-166. doi: 10.1016/S0140-6736(16)31399-X. Epub 2016 Nov 30.
4
Effect of Financial Stress and Positive Financial Behaviors on Cost-Related Nonadherence to Health Regimens Among Adults in a Community-Based Setting.在社区环境中，经济压力和积极财务行为对成年人与费用相关的健康方案治疗依从性的影响。
Prev Chronic Dis. 2016 Apr 7;13:E46. doi: 10.5888/pcd13.160005.
5
Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.氟替卡松加沙美特罗与氟替卡松单药治疗严重哮喘事件的比较。
N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.
6
Shared treatment decision making improves adherence and outcomes in poorly controlled asthma.共同制定治疗决策可改善控制不佳的哮喘患者的依从性和结局。
Am J Respir Crit Care Med. 2010 Mar 15;181(6):566-77. doi: 10.1164/rccm.200906-0907OC. Epub 2009 Dec 17.
7
Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease.成本是使用吸入性糖皮质激素治疗阻塞性肺病的主要障碍。
Med J Aust. 2009 Sep 21;191(6):319-23. doi: 10.5694/j.1326-5377.2009.tb02815.x.
8
Treatment patterns in the months prior to and after asthma-related emergency department visit.哮喘相关急诊科就诊前后数月的治疗模式。
Chest. 2004 Jul;126(1):75-80. doi: 10.1378/chest.126.1.75.
9
Low-dose inhaled corticosteroids and the prevention of death from asthma.低剂量吸入性糖皮质激素与哮喘死亡的预防
N Engl J Med. 2000 Aug 3;343(5):332-6. doi: 10.1056/NEJM200008033430504.
Zotero 插件